Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNS NASDAQ:AXGN NASDAQ:EYE NASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$12.34+3.1%$11.61$9.30▼$25.36$554.05M1.12794,473 shs627,434 shsAXGNAxoGen$15.61-0.6%$13.37$9.22▼$21.00$742.64M1.031.66 million shs833,831 shsEYENational Vision$22.79+3.9%$24.09$9.56▼$25.67$1.82B1.232.30 million shs2.73 million shsSKINBeauty Health$2.00$1.95$0.78▼$2.56$263.80M1.231.42 million shs511,985 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical+3.14%+3.73%+9.35%-0.02%-48.71%AXGNAxoGen-0.64%-3.28%+24.38%+44.54%+18.71%EYENational Vision+3.87%-6.56%-9.09%+9.25%+122.12%SKINBeauty Health0.00%-2.44%+25.00%+25.00%+16.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVNSAvanos Medical2.6029 of 5 stars0.01.00.00.03.53.32.5AXGNAxoGen3.3054 of 5 stars3.54.00.00.03.51.70.6EYENational Vision3.6049 of 5 stars3.32.00.03.33.40.80.0SKINBeauty Health1.6934 of 5 stars3.00.00.00.02.83.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 2.00HoldN/AN/AAXGNAxoGen 3.00Buy$26.0066.56% UpsideEYENational Vision 2.60Moderate Buy$24.738.50% UpsideSKINBeauty Health 2.00Hold$2.6331.25% UpsideCurrent Analyst Ratings BreakdownLatest SKIN, EYE, AXGN, and AVNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/12/2025AVNSAvanos MedicalZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold8/7/2025EYENational VisionThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$17.00 ➝ $22.008/7/2025EYENational VisionWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$24.00 ➝ $27.008/7/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$30.00 ➝ $28.008/1/2025SKINBeauty HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$3.00 ➝ $4.007/30/2025EYENational VisionRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$36.007/23/2025EYENational VisionWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$15.00 ➝ $24.007/8/2025EYENational VisionUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.007/8/2025EYENational VisionNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$30.007/8/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$17.00 ➝ $30.006/18/2025EYENational VisionBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.00(Data available from 9/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$687.80M0.83$12.21 per share1.01$16.73 per share0.74AXGNAxoGen$187.34M3.83N/AN/A$2.44 per share6.40EYENational Vision$1.82B0.99$1.63 per share14.02$10.74 per share2.12SKINBeauty Health$334.30M0.76$0.06 per share32.90$0.58 per share3.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$392.10M-$10.07N/A7.13N/A-66.89%6.16%4.57%10/29/2025 (Estimated)AXGNAxoGen-$9.96M-$0.10N/AN/AN/A-2.29%-4.43%-2.34%11/6/2025 (Estimated)EYENational Vision-$28.50M-$0.18N/A84.412.71-0.75%3.56%1.49%11/5/2025 (Estimated)SKINBeauty Health-$29.10M-$0.28N/AN/AN/A-6.13%-32.82%-2.96%11/11/2025 (Estimated)Latest SKIN, EYE, AXGN, and AVNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025SKINBeauty Health-$0.06$0.03+$0.09$0.03$74.67 million$78.20 million8/6/2025Q2 2025EYENational Vision$0.12$0.18+$0.06$0.11$469.21 million$486.42 million8/5/2025Q2 2025AVNSAvanos Medical$0.18$0.17-$0.01-$1.66$165.50 million$175.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AAXGNAxoGenN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.122.641.58AXGNAxoGen0.594.142.67EYENational Vision0.300.520.31SKINBeauty Health4.915.154.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%AXGNAxoGen80.29%EYENational VisionN/ASKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.64%AXGNAxoGen2.78%EYENational Vision2.70%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical4,04046.40 million45.18 millionOptionableAXGNAxoGen45046.01 million44.73 millionOptionableEYENational Vision13,41179.20 million77.06 millionOptionableSKINBeauty Health1,030126.82 million74.83 millionOptionableSKIN, EYE, AXGN, and AVNS HeadlinesRecent News About These CompaniesBlack Women Thriving Hosts Third Annual Event Celebrating Beauty And Community On Martha’s VineryardSeptember 3 at 4:54 PM | blackenterprise.comBInside Kay Beauty: Katrina Kaif’s mission to bring South Asian beauty to the worldSeptember 3 at 4:54 PM | msn.com10 viral K-beauty products that will transform your skinSeptember 3 at 11:53 AM | msn.com2025’s Best Shoppable Skin Care Products, Selected by ELLE EditorsSeptember 3 at 11:53 AM | yahoo.comSelena Gomezs beauty secrets every woman in her 30s should followSeptember 3 at 6:52 AM | msn.comHome Bargains slashes £18 beauty essential for 'healthy, glowing skin' to £3September 3 at 6:52 AM | msn.com5 skin-tightening treatments for the face that actually deliver resultsSeptember 2 at 11:13 AM | msn.comDrink this for Extreme Hair Growth and Perfect Skin!September 2 at 2:06 AM | msn.comSofía Vergaras secrets for radiant, glowing skin at 50: Natural beauty and timeless habitsSeptember 1 at 8:05 PM | msn.comNighttime beauty routines for women: Tips for glowing, healthy skinSeptember 1 at 8:05 PM | msn.comSoap vs hand sanitiser: Understanding the risks of overuse and maintaining healthy skin with safer alternativesAugust 30, 2025 | msn.comMultiple skin-care products, hand sanitizers recalled because of serious contamination threatAugust 29, 2025 | msn.comThe Ultimate Guide To Taking Care Of The Skin Under Your Eyes, According To DermatologistsAugust 29, 2025 | msn.comTimeless Beauty: Anne Hathaway's 15 Secrets to Ageless, Glowing SkinAugust 29, 2025 | msn.comHow Lindsay Lohan restored the beauty and youth of her face: secrets revealedAugust 28, 2025 | msn.comElsa Pataky reveals the beauty secret she learned from her mother: 'I love that it's stuck with me'August 28, 2025 | hola.comHYou've Definitely Seen Hypochlorous Acid Spray All Over Social Media. Here's What It Does For Skin.August 28, 2025 | msn.comDebut secures $20 million to enhance skin longevity ingredient researchAugust 27, 2025 | cosmeticsbusiness.comCBoost Collagen Naturally With These Skin Care TipsAugust 27, 2025 | msn.comHair loss sufferers 'couldn't believe' growth of hair boosted by beauty bundleAugust 27, 2025 | express.co.ukBeauty Health (NASDAQ:SKIN) Upgraded by Wall Street Zen to Buy RatingAugust 10, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesD-Wave Delivers Growth Shock—Investors Eye Quantum FutureBy Nathan Reiff | August 8, 2025This Railroad Stock Is Chugging Along to a New All-Time HighBy Jordan Chussler | August 20, 2025Does Broadcom Have a VMware Problem? Goldman Eyes Upside in NTNXBy Leo Miller | August 6, 2025As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes BackBy Gabriel Osorio-Mazilli | August 25, 2025DraftKings Posts Record Quarter, Eyes ProfitabilityBy Chris Markoch | August 8, 2025SKIN, EYE, AXGN, and AVNS Company DescriptionsAvanos Medical NYSE:AVNS$12.34 +0.38 (+3.14%) Closing price 09/3/2025 03:59 PM EasternExtended Trading$12.34 +0.01 (+0.08%) As of 09/3/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.AxoGen NASDAQ:AXGN$15.61 -0.10 (-0.64%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$15.13 -0.48 (-3.07%) As of 09/3/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.National Vision NASDAQ:EYE$22.79 +0.85 (+3.87%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$22.79 0.00 (0.00%) As of 09/3/2025 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Beauty Health NASDAQ:SKIN$2.00 0.00 (0.00%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$2.00 0.00 (0.00%) As of 09/3/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Wall Street Punishes Dell's Record Quarter: Why They Are Wrong Taiwan Semiconductor Falls on China News—Buy The Dip? CrowdStrike Tests $412 Support as Options Traders Turn Bullish What to Expect From the Q3 Reporting Season IREN Is Up 186% YTD on AI Pivot—And It’s Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
